Our investigations were restricted to activation of the canonical NF-κB pathway, however the model presented here provides a tool for future work investigating the role of non-canonical pathway activation in the TME through CD40 or BAFF, both of which have been found to be prognostically significant in DLBCL (16, 18, 63). This evidence concerns the gene CD40 and diffuse large B-cell lymphoma.